Similar articles

• Butadiene and lymphatic and hematopoietic cancer.

  Matanoski GM, Santos-Burgoa C. Matanoski GM, et al. Epidemiology. 1994 Mar;5(2):261-3. doi: 10.1097/00001648-199403000-00020. Epidemiology. 1994. PMID: 8173004 No abstract available.
• Butadiene epidemiology re-interpreted, again.

  Park RM. Park RM. Epidemiology. 1993 Nov;4(6):559-61. doi: 10.1097/00001648-199311000-00020. Epidemiology. 1993. PMID: 8268291 No abstract available.
• Toxicology and epidemiology of 1,3-butadiene.

  Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. Himmelstein MW, et al. Crit Rev Toxicol. 1997 Jan;27(1):1-108. doi: 10.3109/10408449709037482. Crit Rev Toxicol. 1997. PMID: 9115622 Review. No abstract available.
• Exposure to butadiene and lymphatic and hematopoietic cancer.

  Cole P, Delzell E, Acquavella J. Cole P, et al. Epidemiology. 1993 Mar;4(2):96-103. doi: 10.1097/00001648-199303000-00004. Epidemiology. 1993. PMID: 8452913 Review.
• Assessment of the health hazards of 1,3-butadiene and styrene. Meeting report.

  Heseltine E, Peltonen K, Sorsa M, Vainio H. Heseltine E, et al. J Occup Med. 1993 Nov;35(11):1089-95. doi: 10.1097/00043764-199311000-00010. J Occup Med. 1993. PMID: 8295032 No abstract available.